Pembrolizumab with chemoradiotherapy followed by pembrolizumab for stage III–IVa cervical cancer: is the ENGOT‐cx11/GOG‐3047/KEYNOTE‐A18 trial practice changing?
Year: 2025
Type: article
Source: Cancer
DOI: 10.1002/cncr.35749
Authors: Bart M. F. Penninx, Michael J. Samson, John‐John B. Schnog
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407197228